- Home
- NYCB vs AXSM Comparison
NYCB vs AXSM Comparison
Compare NYCB & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYCB
- AXSM
- Stock Information
- Founded
- NYCB 1859
- AXSM 2012
- Country
- NYCB United States
- AXSM United States
- Employees
- NYCB N/A
- AXSM N/A
- Industry
- NYCB Banks
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- NYCB Finance
- AXSM Health Care
- Exchange
- NYCB Nasdaq
- AXSM Nasdaq
- Market Cap
- NYCB 4.4B
- AXSM 4.4B
- IPO Year
- NYCB 1993
- AXSM 2015
- Fundamental
- Price
- NYCB $11.45
- AXSM $95.84
- Analyst Decision
- NYCB Hold
- AXSM Strong Buy
- Analyst Count
- NYCB 15
- AXSM 14
- Target Price
- NYCB $13.58
- AXSM $124.57
- AVG Volume (30 Days)
- NYCB 6.4M
- AXSM 405.5K
- Earning Date
- NYCB 10-24-2024
- AXSM 11-04-2024
- Dividend Yield
- NYCB 6.01%
- AXSM N/A
- EPS Growth
- NYCB N/A
- AXSM N/A
- EPS
- NYCB N/A
- AXSM N/A
- Revenue
- NYCB $2,026,000,000.00
- AXSM $291,489,000.00
- Revenue This Year
- NYCB N/A
- AXSM $42.50
- Revenue Next Year
- NYCB N/A
- AXSM $69.28
- P/E Ratio
- NYCB N/A
- AXSM N/A
- Revenue Growth
- NYCB N/A
- AXSM 59.73
- 52 Week Low
- NYCB $5.10
- AXSM $55.02
- 52 Week High
- NYCB $34.92
- AXSM $98.40
- Technical
- Relative Strength Index (RSI)
- NYCB 56.63
- AXSM 64.19
- Support Level
- NYCB $9.51
- AXSM $89.24
- Resistance Level
- NYCB $12.42
- AXSM $96.71
- Average True Range (ATR)
- NYCB 0.59
- AXSM 3.66
- MACD
- NYCB 0.14
- AXSM 0.02
- Stochastic Oscillator
- NYCB 66.67
- AXSM 87.05
About NYCB New York Community Bancorp Inc.
New York Community Bancorp Inc is the bank holding company. It is a New York State-chartered savings bank that operates through eight local divisions: Queens County Savings Bank, Roslyn Savings Bank, Richmond County Savings Bank, Roosevelt Savings Bank, and Atlantic Bank in New York; Garden State Community Bank in New Jersey; Ohio Savings Bank in Ohio, and AmTrust Bank in Florida and Arizona. The bank competes for depositors in diverse markets with a comprehensive menu of products and services, and access to multiple service channels, including online banking, mobile banking, and banking by phone. It is also a producer of multi-family loans in New York City.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.